{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:36:00Z","timestamp":1794317760660,"version":"4.9.0"},"reference-count":266,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"P30AG035982"},{"name":"Frank and Evangeline Thompson Alzheimer's Treatment Program Fund"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.bbadis.2013.09.010","type":"journal-article","created":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T02:14:29Z","timestamp":1379902469000},"page":"1219-1231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":702,"title":["The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectives"],"prefix":"10.1016","volume":"1842","author":[{"given":"Russell H.","family":"Swerdlow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaharyar M.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2013.09.010_bb0005","first-page":"146","article-title":"Uber eine eigenartige Erkrankung der Hirnrinde","volume":"64","author":"Alzheimer","year":"1907","journal-title":"Allg. Z. Psychiat. Psych.-Gerichtl. Med."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0010","series-title":"Klinishce Psychiatrie","article-title":"Psychiatrie. Ein Lehrbuch fur Studierende und Arzte","author":"Kraepelin","year":"1910"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0015","first-page":"643","article-title":"Etude histochimique des plaques seniles","volume":"9","author":"Divry","year":"1927","journal-title":"J. Belg. Neurol. Psychiatry"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0020","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0025","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","article-title":"The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor","volume":"325","author":"Kang","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0035","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.36.11.1497","article-title":"Origin of the distinction between Alzheimer's disease and senile dementia: how history can clarify nosology","volume":"36","author":"Amaducci","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneur.1976.00500040001001","article-title":"Editorial: the prevalence and malignancy of Alzheimer disease. A major killer","volume":"33","author":"Katzman","year":"1976","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0045","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.neurobiolaging.2006.06.021","article-title":"Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?","volume":"28","author":"Swerdlow","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0050","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0055","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0060","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome 1 familial Alzheimer's disease locus","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0065","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/19077","article-title":"Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity","volume":"398","author":"Wolfe","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0075","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0085","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A beta oligomers \u2014 a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0090","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0100","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0105","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1089\/ars.2011.4149","article-title":"Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease","volume":"16","author":"Swerdlow","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12640-011-9272-9","article-title":"Alzheimer's disease pathologic cascades: who comes first, what drives what","volume":"22","author":"Swerdlow","year":"2012","journal-title":"Neurotox. Res."},{"issue":"Suppl. 2","key":"10.1016\/j.bbadis.2013.09.010_bb0115","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.3233\/JAD-2010-100339","article-title":"The Alzheimer's disease mitochondrial cascade hypothesis","volume":"20","author":"Swerdlow","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","article-title":"A \u201cmitochondrial cascade hypothesis\u201d for sporadic Alzheimer's disease","volume":"63","author":"Swerdlow","year":"2004","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0125","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.expneurol.2009.01.011","article-title":"The Alzheimer's disease mitochondrial cascade hypothesis: an update","volume":"218","author":"Swerdlow","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0130","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.bbadis.2011.08.012","article-title":"Brain aging, Alzheimer's disease, and mitochondria","volume":"1812","author":"Swerdlow","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0135","first-page":"347","article-title":"Pathogenesis of Alzheimer's disease","volume":"2","author":"Swerdlow","year":"2007","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature02517","article-title":"Premature ageing in mice expressing defective mitochondrial DNA polymerase","volume":"429","author":"Trifunovic","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0145","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1112125","article-title":"Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging","volume":"309","author":"Kujoth","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0150","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature12474","article-title":"Germline mitochondrial DNA mutations aggravate ageing and can impair brain development","volume":"501","author":"Ross","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0155","series-title":"Proceedings of the 1989 Scientfic Meeting of the American Society for Neurological Investigation: New Developments in Neuromuscular Disease","article-title":"Sporadic neurologic disease and the electron transport chain: a hypothesis","author":"Parker","year":"1990"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0160","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","article-title":"Abnormalities of the electron transport chain in idiopathic Parkinson's disease","volume":"26","author":"Parker","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0165","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0140-6736(89)92145-4","article-title":"Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases","volume":"1","author":"Linnane","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0170","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1126\/science.1533953","article-title":"Mitochondrial genetics: a paradigm for aging and degenerative diseases?","volume":"256","author":"Wallace","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/hmg\/11.2.133","article-title":"High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain","volume":"11","author":"Lin","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0180","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1532-5415.1972.tb00787.x","article-title":"The biologic clock: the mitochondria?","volume":"20","author":"Harman","year":"1972","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0185","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF02834249","article-title":"Alzheimer's disease. A metabolic systems degeneration?","volume":"2","author":"Blass","year":"1984","journal-title":"Neurochem. Pathol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0190","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archneur.1988.00520320022009","article-title":"Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease","volume":"45","author":"Gibson","year":"1988","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0195","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJM198509053131013","article-title":"Altered glucose metabolism in fibroblasts from patients with Alzheimer's disease","volume":"313","author":"Sims","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0200","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ana.410210507","article-title":"Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease","volume":"21","author":"Sims","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0006-8993(87)91553-8","article-title":"Mitochondrial function in brain tissue in primary degenerative dementia","volume":"436","author":"Sims","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/002383099300600101","article-title":"Brain oxidative energy and related metabolism, neuronal stress, and Alzheimer's disease: a speculative synthesis","volume":"6","author":"Hoyer","year":"1993","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0215","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0531-5565(00)00156-X","article-title":"Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update","volume":"35","author":"Hoyer","year":"2000","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0220","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.40.8.1302","article-title":"Cytochrome oxidase deficiency in Alzheimer's disease","volume":"40","author":"Parker","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0225","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.410380304","article-title":"Aging, energy, and oxidative stress in neurodegenerative diseases","volume":"38","author":"Beal","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0230","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jnr.10389","article-title":"Role of mitochondrial dysfunction in Alzheimer's disease","volume":"70","author":"Castellani","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0235","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","article-title":"Mitochondrial abnormalities in Alzheimer's disease","volume":"21","author":"Hirai","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0240","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00000441-199409000-00003","article-title":"Brain glucose metabolism in Alzheimer's disease","volume":"308","author":"Swerdlow","year":"1994","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0245","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s007020050098","article-title":"The effects of perturbed energy metabolism on the processing of amyloid precursor protein in PC12 cells","volume":"105","author":"Webster","year":"1998","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0250","doi-asserted-by":"crossref","first-page":"13623","DOI":"10.1016\/S0021-9258(17)36875-8","article-title":"Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative","volume":"269","author":"Gabuzda","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0255","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-3940(97)00536-3","article-title":"Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells","volume":"231","author":"Gasparini","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0260","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7","article-title":"Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways","volume":"48","author":"Khan","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0265","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1046\/j.1471-4159.1995.64062660.x","article-title":"Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease","volume":"64","author":"Smith","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0270","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archneur.56.12.1449","article-title":"The role of oxidative stress in Alzheimer disease","volume":"56","author":"Markesbery","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0275","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/archneur.1990.00530080046009","article-title":"Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation","volume":"47","author":"Blass","year":"1990","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0280","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbr.2004.01.016","article-title":"A chronic Alzheimer's model evoked by mitochondrial poison sodium azide for pharmacological investigations","volume":"154","author":"Szabados","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0285","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1172\/JCI17271","article-title":"Mechano-oxidative coupling by mitochondria induces proinflammatory responses in lung venular capillaries","volume":"111","author":"Ichimura","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0290","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1096\/fj.05-3735fje","article-title":"Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease","volume":"19","author":"Caspersen","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0295","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.1091230","article-title":"ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease","volume":"304","author":"Lustbader","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0300","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"Manczak","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0305","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.200207030","article-title":"Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells","volume":"161","author":"Anandatheerthavarada","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0310","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1177\/1073858407303536","article-title":"Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease","volume":"13","author":"Anandatheerthavarada","year":"2007","journal-title":"Neuroscientist"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0315","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1523\/JNEUROSCI.1469-06.2006","article-title":"Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction","volume":"26","author":"Devi","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0320","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1523\/JNEUROSCI.4276-04.2005","article-title":"Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42","volume":"25","author":"Crouch","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0325","doi-asserted-by":"crossref","first-page":"51654","DOI":"10.1074\/jbc.M404500200","article-title":"Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria","volume":"279","author":"Hansson","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0330","doi-asserted-by":"crossref","first-page":"13145","DOI":"10.1073\/pnas.0806192105","article-title":"The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae","volume":"105","author":"Hansson Petersen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2004.12.131","article-title":"Widespread gamma-secretase activity in the cell, but do we need it at the mitochondria?","volume":"328","author":"Teng","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0340","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","article-title":"Mitochondria, oxidants, and aging","volume":"120","author":"Balaban","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0345","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0300-9084(00)88881-1","article-title":"Aging and mitochondria","volume":"80","author":"Gadaleta","year":"1998","journal-title":"Biochimie"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0350","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0005-2728(00)00177-8","article-title":"Mitochondrial bioenergetics in aging","volume":"1459","author":"Lenaz","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0355","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ana.21915","article-title":"Dementia incidence continues to increase with age in the oldest old: the 90+ study","volume":"67","author":"Corrada","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0360","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/01.wnl.0000310773.65918.cd","article-title":"Prevalence of dementia after age 90: results from the 90+ study","volume":"71","author":"Corrada","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0365","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/archneurol.2011.82","article-title":"Mild cognitive impairment, dementia, and their subtypes in oldest old women","volume":"68","author":"Yaffe","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0370","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/WNL.51.3.728","article-title":"The incidence of dementia: a meta-analysis","volume":"51","author":"Jorm","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0375","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/01.wnl.0000319660.82871.17","article-title":"If we live long enough, will we all be demented?: redux","volume":"71","author":"Hogan","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0380","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1212\/WNL.56.12.1690","article-title":"Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study","volume":"56","author":"Polvikoski","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0385","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000090252","article-title":"Incidence of dementia in very elderly individuals: a clinical, neuropathological and molecular genetic study","volume":"26","author":"Polvikoski","year":"2006","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0390","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0022-510X(92)90047-O","article-title":"Neuropathological background of twenty-seven centenarian brains","volume":"108","author":"Mizutani","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0395","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.neurobiolaging.2008.04.010","article-title":"No disease in the brain of a 115-year-old woman","volume":"29","author":"den Dunnen","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0400","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/iub.46","article-title":"Brain mitochondrial dysfunction in aging","volume":"60","author":"Boveris","year":"2008","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0405","doi-asserted-by":"crossref","first-page":"C670","DOI":"10.1152\/ajpcell.00213.2006","article-title":"The mitochondrial energy transduction system and the aging process","volume":"292","author":"Navarro","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0410","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0169-328X(97)00278-7","article-title":"Reduced steady-state levels of mitochondrial RNA and increased mitochondrial DNA amount in human brain with aging","volume":"52","author":"Barrientos","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0415","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1471-4159.1992.tb09439.x","article-title":"Brain cytochrome oxidase in Alzheimer's disease","volume":"59","author":"Kish","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0420","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1046\/j.1471-4159.1994.63062179.x","article-title":"Cortical cytochrome oxidase activity is reduced in Alzheimer's disease","volume":"63","author":"Mutisya","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0425","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1212\/WNL.44.6.1090","article-title":"Electron transport chain defects in Alzheimer's disease brain","volume":"44","author":"Parker","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0430","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0197-4580(00)00112-3","article-title":"A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients","volume":"21","author":"Maurer","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0435","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1073\/pnas.71.5.1681","article-title":"Cytoplasmic inheritance of chloramphenicol resistance in mouse tissue culture cells","volume":"71","author":"Bunn","year":"1974","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0440","first-page":"966","article-title":"Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals \u2014 and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers","volume":"54","author":"Chomyn","year":"1994","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0445","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1126\/science.2814477","article-title":"Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation","volume":"246","author":"King","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0450","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1523\/JNEUROSCI.17-12-04612.1997","article-title":"Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease","volume":"17","author":"Sheehan","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0455","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1212\/WNL.49.4.918","article-title":"Cybrids in Alzheimer's disease: a cellular model of the disease?","volume":"49","author":"Swerdlow","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0460","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/1567205011310020008","article-title":"Prodromal metabolic phenotype in MCI cybrids: implications for Alzheimers disease","volume":"10","author":"Silva","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0465","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1093\/hmg\/ddt247","article-title":"Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines","volume":"22","author":"Silva","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0470","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMcp0910237","article-title":"Clinical practice. Mild cognitive impairment","volume":"364","author":"Petersen","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0475","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","article-title":"Current concepts in mild cognitive impairment","volume":"58","author":"Petersen","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0480","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0485","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archneur.58.3.397","article-title":"Mild cognitive impairment represents early-stage Alzheimer disease","volume":"58","author":"Morris","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0490","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1016\/j.bbagen.2013.01.002","article-title":"Glycolysis\u2013respiration relationships in a neuroblastoma cell line","volume":"1830","author":"Swerdlow","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0495","first-page":"1","article-title":"Altered cerebral energy metabolism in Alzheimer's disease: a PET study","volume":"35","author":"Fukuyama","year":"1994","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0500","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.286.17.2120","article-title":"Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome","volume":"286","author":"Silverman","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0505","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/brain\/104.4.753","article-title":"Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography","volume":"104","author":"Frackowiak","year":"1981","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0510","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ana.410360510","article-title":"Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease","volume":"36","author":"Mecocci","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0515","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/geno.1994.1525","article-title":"Marked changes in mitochondrial DNA deletion levels in Alzheimer brains","volume":"23","author":"Corral-Debrinski","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0520","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0027-5107(97)00158-9","article-title":"Elevated levels of the Kearns\u2013Sayre syndrome mitochondrial DNA deletion in temporal cortex of Alzheimer's patients","volume":"379","author":"Hamblet","year":"1997","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0525","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/labinvest.3780140","article-title":"Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease","volume":"80","author":"de la Monte","year":"2000","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0530","doi-asserted-by":"crossref","first-page":"10726","DOI":"10.1073\/pnas.0403649101","article-title":"Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication","volume":"101","author":"Coskun","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 2","key":"10.1016\/j.bbadis.2013.09.010_bb0535","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.3233\/JAD-2010-100351","article-title":"Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia","volume":"20","author":"Coskun","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0540","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/bbrc.2000.2885","article-title":"The frequency of point mutations in mitochondrial DNA is elevated in the Alzheimer's brain","volume":"273","author":"Chang","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0545","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1385\/JMN:16:1:41","article-title":"Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (mtDNA)","volume":"16","author":"Brown","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0550","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1073\/pnas.94.9.4526","article-title":"Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease","volume":"94","author":"Davis","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0555","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.ejhg.5200629","article-title":"Is mitochondrial DNA depletion involved in Alzheimer's disease?","volume":"9","author":"Rodriguez-Santiago","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0560","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1056\/NEJM198604103141506","article-title":"Alzheimer's disease","volume":"314","author":"Katzman","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0565","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1212\/WNL.47.1.254","article-title":"Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance","volume":"47","author":"Edland","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0570","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1212\/WNL.43.7.1377","article-title":"A comparison of familial and sporadic Alzheimer's disease","volume":"43","author":"Duara","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0575","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ajmg.10648","article-title":"Evidence for parent of origin effect in late-onset Alzheimer disease","volume":"114","author":"Bassett","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0580","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/archneur.64.12.1743","article-title":"Variability of age at onset in siblings with familial Alzheimer disease","volume":"64","author":"Gomez-Tortosa","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0585","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1212\/WNL.0b013e3181c67833","article-title":"Association of parental dementia with cognitive and brain MRI measures in middle-aged adults","volume":"73","author":"Debette","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0590","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1212\/WNL.55.2.302","article-title":"Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies","volume":"55","author":"Chinnery","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0595","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10571-006-9126-9","article-title":"Do haplogroups H and U act to increase the penetrance of Alzheimer's disease?","volume":"27","author":"Fesahat","year":"2007","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0600","doi-asserted-by":"crossref","first-page":"709061","DOI":"10.4061\/2011\/709061","article-title":"May \u201cmitochondrial eve\u201d and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease?","volume":"2011","author":"Ienco","year":"2011","journal-title":"Int. J. Alzheimers. Dis."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0605","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.neurobiolaging.2010.04.031","article-title":"Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort","volume":"31","author":"Lakatos","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0610","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.neurobiolaging.2008.01.004","article-title":"Mitochondrial haplogroup H and Alzheimer's disease \u2014 is there a connection?","volume":"30","author":"Maruszak","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0615","doi-asserted-by":"crossref","first-page":"e12037","DOI":"10.1371\/journal.pone.0012037","article-title":"Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease","volume":"5","author":"Santoro","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0620","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10863-009-9240-8","article-title":"Mitochondrial haplogroups associated with Japanese Alzheimer's patients","volume":"41","author":"Takasaki","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0625","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neulet.2004.04.051","article-title":"Analysis of European mitochondrial haplogroups with Alzheimer disease risk","volume":"365","author":"van der Walt","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0630","doi-asserted-by":"crossref","first-page":"3e75158","DOI":"10.1371\/journal.pone.0074158","article-title":"Mitochondrial haplotypes associated with biomarkers for Alzheimer's disease","volume":"8","author":"Ridge","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0635","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1073\/pnas.92.15.6892","article-title":"A mitochondrial DNA clone is associated with increased risk for Alzheimer disease","volume":"92","author":"Hutchin","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0640","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/geno.1993.1299","article-title":"Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients","volume":"17","author":"Shoffner","year":"1993","journal-title":"Genomics"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0645","doi-asserted-by":"crossref","first-page":"19067","DOI":"10.1073\/pnas.0705036104","article-title":"Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism","volume":"104","author":"Mosconi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0650","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.neurobiolaging.2011.01.001","article-title":"Structural brain changes in normal individuals with a maternal history of Alzheimer's","volume":"32","author":"Berti","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0655","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1479-7364-4-3-170","article-title":"Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes","volume":"4","author":"Mosconi","year":"2010","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0660","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.biopsych.2010.07.011","article-title":"Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's","volume":"68","author":"Mosconi","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0665","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1212\/01.wnl.0000333247.51383.43","article-title":"Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease","volume":"72","author":"Mosconi","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0670","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1073\/pnas.0914141107","article-title":"Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's","volume":"107","author":"Mosconi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0675","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/WNL.0b013e31820e7b74","article-title":"Progressive regional atrophy in normaladults with a maternal history of Alzheimer disease","volume":"76","author":"Honea","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0680","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1212\/WNL.0b013e3181c918cb","article-title":"Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease","volume":"74","author":"Honea","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0685","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3233\/JAD-2012-120676","article-title":"Maternal family history is associated with Alzheimer's disease biomarkers","volume":"31","author":"Honea","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0690","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.neurobiolaging.2010.07.020","article-title":"Effects of ApoE4 and maternal history of dementia on hippocampal atrophy","volume":"33","author":"Andrawis","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0695","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/cns.12028","article-title":"A cross-sectional study on cerebrospinal fluid biomarker levels in cognitively normal elderly subjects with or without a family history of Alzheimer's disease","volume":"19","author":"Liu","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0700","article-title":"Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease","author":"Okonkwo","year":"2013","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0705","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neuroimage.2012.03.083","article-title":"Cognitively normal individuals with AD parents may be at risk for developing aging-related cortical thinning patterns characteristic of AD","volume":"61","author":"Reiter","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0710","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JAD-2011-110866","article-title":"Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease","volume":"27","author":"Mosconi","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0715","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archneurol.2010.88","article-title":"An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease","volume":"67","author":"Roses","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0720","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jalz.2011.11.006","article-title":"Longitudinal modeling of cognitive aging and the TOMM40 effect","volume":"8","author":"Caselli","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0725","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3233\/JAD-2011-110743","article-title":"TOMM40 rs10524523 polymorphism's role in late-onset Alzheimer's disease and in longevity","volume":"28","author":"Maruszak","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0730","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jalz.2011.10.005","article-title":"A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging","volume":"8","author":"Hayden","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0735","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jalz.2010.11.012","article-title":"The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE epsilon3\/epsilon3 genotype","volume":"7","author":"Johnson","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0740","doi-asserted-by":"crossref","first-page":"e6501","DOI":"10.1371\/journal.pone.0006501","article-title":"Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease","volume":"4","author":"Potkin","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0745","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/acel.12039","article-title":"Genome-wide linkage analysis for human longevity: Genetics of Healthy Aging Study","volume":"12","author":"Beekman","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0750","doi-asserted-by":"crossref","first-page":"e59676","DOI":"10.1371\/journal.pone.0059676","article-title":"Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case\u2013control cohort","volume":"8","author":"Elias-Sonnenschein","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0755","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/clpt.2012.222","article-title":"Using genetics to enable studies on the prevention of Alzheimer's disease","volume":"93","author":"Crenshaw","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0760","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jalz.2012.10.009","article-title":"TOMM40 and APOE: requirements for replication studies of association with age of disease onset and enrichment of a clinical trial","volume":"9","author":"Roses","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0765","doi-asserted-by":"crossref","first-page":"e30994","DOI":"10.1371\/journal.pone.0030994","article-title":"Characterization of the poly-T variant in the TOMM40 gene in diverse populations","volume":"7","author":"Linnertz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0770","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jalz.2012.06.009","article-title":"TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE varepsilon3\/varepsilon3","volume":"9","author":"Li","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0775","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/jhg.2011.123","article-title":"Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE","volume":"57","author":"Bekris","year":"2012","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0780","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.neurobiolaging.2011.05.023","article-title":"Genetic variation in APOE cluster region and Alzheimer's disease risk","volume":"32","author":"Cervantes","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0785","first-page":"1034","article-title":"Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage","volume":"48","author":"Pericak-Vance","year":"1991","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0790","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0795","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0800","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/tpj.2009.69","article-title":"A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease","volume":"10","author":"Roses","year":"2010","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0805","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/archneurol.2012.1935","article-title":"TOMM40 association with Alzheimer disease: tales of APOE and linkage disequilibrium","volume":"69","author":"Guerreiro","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0810","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archneurol.2011.155","article-title":"Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease","volume":"68","author":"Cruchaga","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0815","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/archneurol.2012.2052","article-title":"Comprehensive search for Alzheimer disease susceptibility loci in the APOE region","volume":"69","author":"Jun","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0820","doi-asserted-by":"crossref","first-page":"18694","DOI":"10.1073\/pnas.0508254102","article-title":"Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity","volume":"102","author":"Chang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0825","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","article-title":"Apolipoprotein e sets the stage: response to injury triggers neuropathology","volume":"76","author":"Mahley","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0830","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1074\/jbc.M110.151084","article-title":"Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0835","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1326-4-35","article-title":"Apolipoprotein E4 (1\u2013272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells","volume":"4","author":"Nakamura","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0840","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3233\/JAD-2008-13305","article-title":"Mitochondrial transcription factor A (TFAM) gene variation and risk of late-onset Alzheimer's disease","volume":"13","author":"Alvarez","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0845","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neulet.2007.05.010","article-title":"Association study of two genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer's and Parkinson's disease","volume":"420","author":"Belin","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0850","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neulet.2004.07.070","article-title":"Possible association of mitochondrial transcription factor A (TFAM) genotype with sporadic Alzheimer disease","volume":"369","author":"Gunther","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0855","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3233\/JAD-2010-100123","article-title":"Polymorphic variation in cytochrome oxidase subunit genes","volume":"21","author":"Lu","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0860","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/j.1471-4159.2010.06871.x","article-title":"Nerve growth factor attenuates oxidant-induced beta-amyloid neurotoxicity in sporadic Alzheimer's disease cybrids","volume":"114","author":"Onyango","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0865","doi-asserted-by":"crossref","first-page":"17763","DOI":"10.1073\/pnas.1010461107","article-title":"Spatial correlation between brain aerobic glycolysis and amyloid-beta (Abeta) deposition","volume":"107","author":"Vlassenko","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0870","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00401-012-0980-x","article-title":"Mitochondrial DNA polymorphisms specifically modify cerebral beta-amyloid proteostasis","volume":"124","author":"Scheffler","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0875","doi-asserted-by":"crossref","first-page":"14163","DOI":"10.1073\/pnas.0705738104","article-title":"Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease","volume":"104","author":"Fukui","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0880","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.neurobiolaging.2013.04.014","article-title":"Mitochondrial DNA damage in a mouse model of Alzheimer's disease decreases amyloid beta plaque formation","volume":"34","author":"Pinto","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0885","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1161591","article-title":"Amyloid-beta dynamics correlate with neurological status in the injured human brain","volume":"321","author":"Brody","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0890","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1126\/science.1180962","article-title":"Amyloid-beta dynamics are regulated by orexin and the sleep\u2013wake cycle","volume":"326","author":"Kang","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0895","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1073\/pnas.90.11.5191","article-title":"Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices","volume":"90","author":"Nitsch","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0900","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0905","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","article-title":"Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo","volume":"48","author":"Cirrito","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0910","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nn.2801","article-title":"Neuronal activity regulates the regional vulnerability to amyloid-beta deposition","volume":"14","author":"Bero","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0915","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1212\/01.wnl.0000256043.50901.e3","article-title":"Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker","volume":"68","author":"Bateman","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0920","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tics.2011.09.004","article-title":"Lifespan brain activity, beta-amyloid, and Alzheimer's disease","volume":"15","author":"Jagust","year":"2011","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0925","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF02238755","article-title":"Age-related changes in brain: II. Positron emission tomography of frontal and temporal lobe glucose metabolism in normal subjects","volume":"66","author":"De Santi","year":"1995","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0930","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/gps.3840","article-title":"Longitudinal studies of cerebral glucose metabolism in late-life depression and normal aging","volume":"28","author":"Marano","year":"2013","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0935","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0925-4927(01)00126-3","article-title":"Age, sex and laterality effects on cerebral glucose metabolism in healthy adults","volume":"114","author":"Willis","year":"2002","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0940","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuroimage.2013.03.009","article-title":"Relationships between brain metabolism decrease in normal aging and changes in structural and functional connectivity","volume":"76","author":"Chetelat","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0945","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neurobiolaging.2007.05.019","article-title":"Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging","volume":"30","author":"Kalpouzos","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0950","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3174\/ajnr.A2070","article-title":"Effects of age on the glucose metabolic changes in mild cognitive impairment","volume":"31","author":"Kantarci","year":"2010","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0955","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00259-008-0833-y","article-title":"Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease","volume":"35","author":"Li","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0960","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","article-title":"FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease","volume":"36","author":"Mosconi","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0965","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1212\/WNL.0b013e31826c1a8d","article-title":"Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment","volume":"79","author":"Scheef","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0970","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/cercor\/5.3.222","article-title":"Developmental changes in brain metabolism in sedated rhesus macaques and vervet monkeys revealed by positron emission tomography","volume":"5","author":"Jacobs","year":"1995","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0975","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrn1323","article-title":"Insights into the ageing mind: a view from cognitive neuroscience","volume":"5","author":"Hedden","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0980","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1586\/ern.10.162","article-title":"Quantitative structural MRI for early detection of Alzheimer's disease","volume":"10","author":"McEvoy","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbadis.2013.09.010_bb0985","first-page":"A66","article-title":"Amyloid imaging with Pittsburgh Compound-B (PIB) in AD, MCI, and highly intelligent older adults","volume":"66","author":"Rentz","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0990","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb0995","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","article-title":"Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease","volume":"131","author":"Ikonomovic","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1000","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mcna.2012.12.012","article-title":"The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease","volume":"97","author":"Blennow","year":"2013","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1015","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nm1438","article-title":"Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo","volume":"12","author":"Bateman","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/embor.2013.15","article-title":"Physiological release of endogenous tau is stimulated by neuronal activity","volume":"14","author":"Pooler","year":"2013","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1030","doi-asserted-by":"crossref","DOI":"10.1002\/ana.23816","article-title":"Brain injury biomarkers are not dependent on beta-amyloid in normal elderly","author":"Knopman","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrneurol.2013.21","article-title":"Alzheimer disease: Abeta-independent processes \u2014 rethinking preclinical AD","volume":"9","author":"Chetelat","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1040","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-2010-100129","article-title":"Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE epsilon4 allele, the major late-onset Alzheimer's susceptibility gene","volume":"22","author":"Valla","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1045","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJM199603213341202","article-title":"Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E","volume":"334","author":"Reiman","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1050","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/jama.1995.03520360056039","article-title":"Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease","volume":"273","author":"Small","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1055","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1523\/JNEUROSCI.4409-12.2013","article-title":"Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not beta-amyloid in cognitively normal older individuals","volume":"33","author":"Wirth","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1060","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.22628","article-title":"An operational approach to National Institute on Aging\u2013Alzheimer's Association criteria for preclinical Alzheimer disease","volume":"71","author":"Jack","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1065","doi-asserted-by":"crossref","DOI":"10.1002\/ana.23955","article-title":"Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease","author":"Podlesniy","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1075","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1080","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/WNL.0b013e3182840d14","article-title":"Backwaters and rapids on the amyloid river","volume":"80","author":"Burns","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1085","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","article-title":"Brain beta-amyloid load approaches a plateau","volume":"80","author":"Jack","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1090","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0197-4580(00)00229-3","article-title":"The levels of cerebrospinal fluid Abeta40 and Abeta42(43) are regulated age-dependently","volume":"22","author":"Shoji","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1100","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archneur.63.7.936","article-title":"Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition","volume":"63","author":"Peskind","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1105","first-page":"3","article-title":"Increased cerebral blood flow in cognitively normal older adults with amyloid","author":"Schultz","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1110","first-page":"2","article-title":"Region-specific associations of brain glucose metabolism with age and beta-amyloid deposition in normal aging","author":"Oh","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1115","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s004010050997","article-title":"Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology","volume":"97","author":"Nagy","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/NMM:5:2:147","article-title":"Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage","volume":"5","author":"Manczak","year":"2004","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1125","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2013.09.010_bb1130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.archger.2009.09.035","article-title":"Life expectancy in Alzheimer's disease (AD)","volume":"49","author":"Zanetti","year":"2009","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1135","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/archneurol.2011.1841","article-title":"Plasma amyloid-beta as a predictor of dementia and cognitive decline: a systematic review and meta-analysis","volume":"69","author":"Koyama","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1140","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00702-012-0772-4","article-title":"Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease","volume":"119","author":"Rissman","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1145","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1150","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The Global Deterioration Scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1155","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1212\/01.wnl.0000234032.77541.a2","article-title":"Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI","volume":"67","author":"Saykin","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/JAD-2010-1210","article-title":"The outcome of elderly patients with cognitive complaints but normal neuropsychological tests","volume":"19","author":"Nunes","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1165","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-2010-101422","article-title":"Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients","volume":"23","author":"Rami","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1170","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)64847-X","article-title":"Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain","volume":"157","author":"Morishima-Kawashima","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1175","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1056\/NEJMoa0806142","article-title":"Age, neuropathology, and dementia","volume":"360","author":"Savva","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1180","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0197-4580(93)90096-T","article-title":"Beta A4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centenarians","volume":"14","author":"Delaere","year":"1993","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1185","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archneur.62.5.758","article-title":"Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study","volume":"62","author":"Galvin","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1190","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1195","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","article-title":"[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease","volume":"67","author":"Mintun","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1200","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer's disease: a new lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1205","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/01.wnl.0000343853.00346.a4","article-title":"APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old","volume":"72","author":"Berlau","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1210","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pmr.2010.01.001","article-title":"Cognition, aging, and disabilities: conceptual issues","volume":"21","author":"Borson","year":"2010","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"issue":"Suppl. 2","key":"10.1016\/j.bbadis.2013.09.010_bb1215","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1111\/j.1753-4887.2010.00351.x","article-title":"Functional expressions of the aging brain","volume":"68","author":"Folstein","year":"2010","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnins.2011.00025","article-title":"Slowing down: age-related neurobiological predictors of processing speed","volume":"5","author":"Eckert","year":"2011","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1225","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1017\/S1355617710000706","article-title":"Selective review of cognitive aging","volume":"16","author":"Salthouse","year":"2010","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1230","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jama.1996.03530310034029","article-title":"Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study","volume":"275","author":"Snowdon","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1235","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/01.WNL.0000133007.87028.09","article-title":"Worker functions and traits associated with occupations and the development of AD","volume":"63","author":"Smyth","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1240","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00401-010-0719-5","article-title":"Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis","volume":"120","author":"Boche","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1245","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/01.jnen.0000240466.10758.ce","article-title":"Abeta species removal after abeta42 immunization","volume":"65","author":"Nicoll","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1250","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1255","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1260","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jalz.2013.03.007","article-title":"Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU\/US\/CTAD Task Force","volume":"9","author":"Vellas","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1265","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1474-4422(10)70043-0","article-title":"11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study","volume":"9","author":"Rinne","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1270","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1517\/14712598.2013.789856","article-title":"Bapineuzumab and solanezumab for Alzheimer's disease: is the \u2018amyloid cascade hypothesis\u2019 still alive?","volume":"13","author":"Tayeb","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1275","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer's disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1280","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1001\/jama.2009.1866","article-title":"Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial","volume":"302","author":"Green","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1285","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5114\/aoms.2011.20612","article-title":"Tramiprosate in mild-to-moderate Alzheimer's disease \u2014 a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)","volume":"7","author":"Aisen","year":"2011","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1290","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.amjopharm.2009.06.003","article-title":"Drug development for Alzheimer's disease: where are we now and where are we headed?","volume":"7","author":"Sabbagh","year":"2009","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1295","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1300","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1474-4422(12)70144-8","article-title":"Colombia at the centre of preclinical AD research","volume":"11","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1305","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.22615","article-title":"Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders","volume":"70","author":"Jucker","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1310","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1152\/physrev.1997.77.4.1081","article-title":"Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives","volume":"77","author":"Mattson","year":"1997","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1315","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1089\/ars.2007.1676","article-title":"Treating neurodegeneration by modifying mitochondria: potential solutions to a \u201ccomplex\u201d problem","volume":"9","author":"Swerdlow","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1320","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/ph2030150","article-title":"Mitochondrial medicine and the neurodegenerative mitochondriopathies","volume":"2","author":"Swerdlow","year":"2009","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbadis.2013.09.010_bb1325","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.2174\/138161211798072535","article-title":"Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases","volume":"17","author":"Swerdlow","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbadis.2013.09.010_bb1330","article-title":"Bioenergetic medicine","author":"Swerdlow","year":"2013","journal-title":"Br. J. Pharmacol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913002895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913002895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T10:49:22Z","timestamp":1746010162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443913002895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":266,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0925443913002895"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.09.010","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectives","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}